Medexus Pharmaceuticals holds annual shareholder meeting

• Medexus Pharmaceuticals held its virtual annual shareholder meeting on Sept. 24, 2026.
• Shareholders backed the appointment of PricewaterhouseCoopers LLP as auditor.
• Votes also adopted amendments to the equity incentive compensation plan.
• Director nominees listed in the Aug. 10, 2026 circular were elected to serve until the next annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medexus Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609241730NEWSFILECNPR____20260924_315965_1) on September 24, 2026, and is solely responsible for the information contained therein.